Physician profile
Pradip Pathare
NPI 1780657510
$1,612.11
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,173 · 2020: $130 · 2021: $151 · 2022: $125 · 2023: $16.57 · 2024: $16.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $355.75 | 2019-2021 | |
| Celgene Corporation | $176.53 | 2019-2021 | |
| Astellas Pharma US INC | $171.90 | 2019 | |
| Janssen Biotech, INC. | $153.39 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $132.16 | 2019 | |
| Genzyme Corporation | $120.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $67.17 | 2019 | |
| Clovis Oncology, INC. | $57.86 | 2019 | |
| Lilly USA, LLC | $53.53 | 2019-2020 | |
| Tesaro, INC. | $51.56 | 2019 | |
| Abbvie INC. | $44.06 | 2019 | |
| Amgen INC. | $43.86 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.77 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $28.67 | 2020 | |
| Sanofi-Aventis U.S. LLC | $23.29 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.83 | 2020 | |
| Seagen INC. | $16.57 | 2023 | Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $16.46 | 2019 | |
| Incyte Corporation | $16.29 | 2024 | Jakafi |
| Tactile Systems Technology INC | $12.27 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradip Pathare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.